Private Capital Management, LLC
Position in LGND — Ligand Pharmaceuticals Inc
CIK 1588456
NAPLES, FL
Position in LGND
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$40,205,716
+$710,695 QoQ
Shares Held
201,381
-3.6% QoQ
Ownership
1.00%
of shares outstanding
% of Portfolio
4.67%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 32.033806565664094.ToString("F0")%
Shared 67.9661934343359.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Private Capital Management, LLC holds $40,544,216 across 2 Biotechnology names. LGND ranks #1 (99.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
This page
|
201,381 | $40,205,716 | |
| 2 | DMAC |
DiaMedica Therapeutics Inc.
|
50,000 | $338,500 |
All Filings in LGND
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $40,205,716 | 201,381 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $39,495,021 | 208,891 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $40,238,768 | 227,158 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $26,061,481 | 229,253 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $15,573,862 | 148,125 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $14,324,883 | 133,690 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $13,400,049 | 133,880 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $11,333,391 | 134,505 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||